Biologic prosthesis reduces recurrence after laparoscopic paraesophageal hernia repair: A multicenter, prospective, randomized trial

Brant K. Oelschlager*, Carlos A. Pellegrini, John Hunter, Nathaniel Soper, Michael Brunt, Brett Sheppard, Blair Jobe, Nayak Polissar, Lee Mitsumori, James Nelson, L. Swanstrom

*Corresponding author for this work

Research output: Contribution to journalArticle

311 Scopus citations

Abstract

OBJECTIVE: Laparoscopic paraesophageal hernia repair (LPEHR) is associated with a high recurrence rate. Repair with synthetic mesh lowers recurrence but can cause dysphagia and visceral erosions. This trial was designed to study the value of a biologic prosthesis, small intestinal submucosa (SIS), in LPEHR. METHODS: Patients undergoing LPEHR (n = 108) at 4 institutions were randomized to primary repair -1° (n = 57) or primary repair buttressed with SIS (n = 51) using a standardized technique. The primary outcome measure was evidence of recurrent hernia (≥2 cm) on UGI, read by a study radiologist blinded to the randomization status, 6 months after operation. RESULTS: At 6 months, 99 (93%) patients completed clinical symptomatic follow-up and 95 (90%) patients had an UGI. The groups had similar clinical presentations (symptom profile, quality of life, type and size of hernia, esophageal length, and BMI). Operative times (SIS 202 minutes vs. 1° 183 minutes, P = 0.15) and perioperative complications did not differ. There were no operations for recurrent hernia nor mesh-related complications. At 6 months, 4 patients (9%) developed a recurrent hernia >2 cm in the SIS group and 12 patients (24%) in the 1° group (P = 0.04). Both groups experienced a significant reduction in all measured symptoms (heartburn, regurgitation, dysphagia, chest pain, early satiety, and postprandial pain) and improved QOL (SF-36) after operation. There was no difference between groups in either pre or postoperative symptom severity. Patients with a recurrent hernia had more chest pain (2.7 vs. 1.0, P = 0.03) and early satiety (2.8 vs. 1.3, P = 0.02) and worse physical functioning (63 vs. 72, P = 0.03 per SF-36). CONCLUSIONS: Adding a biologic prosthesis during LPEHR reduces the likelihood of recurrence at 6 months, without mesh-related complications or side effects.

Original languageEnglish (US)
Pages (from-to)481-488
Number of pages8
JournalAnnals of surgery
Volume244
Issue number4
DOIs
StatePublished - Oct 1 2006

ASJC Scopus subject areas

  • Surgery

Fingerprint Dive into the research topics of 'Biologic prosthesis reduces recurrence after laparoscopic paraesophageal hernia repair: A multicenter, prospective, randomized trial'. Together they form a unique fingerprint.

  • Cite this

    Oelschlager, B. K., Pellegrini, C. A., Hunter, J., Soper, N., Brunt, M., Sheppard, B., Jobe, B., Polissar, N., Mitsumori, L., Nelson, J., & Swanstrom, L. (2006). Biologic prosthesis reduces recurrence after laparoscopic paraesophageal hernia repair: A multicenter, prospective, randomized trial. Annals of surgery, 244(4), 481-488. https://doi.org/10.1097/01.sla.0000237759.42831.03